Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos

49963

Sigma-Aldrich

β-tri-Calcium phosphate

puriss. p.a., ≥98% β-phase basis (sintered Powder)

Sinônimo(s):

β-TCP, β-Tricalcium phosphate

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):
Ca3O8P2
Número CAS:
7758-87-4
Peso molecular:
310.18
Número CE:
231-840-8
Número MDL:
MFCD00015984
Código UNSPSC:
12352302
ID de substância PubChem:
329757549
NACRES:
NA.55

grau

puriss. p.a.

Ensaio

≥98% β-phase basis (sintered Powder)

forma

powder

Impurezas

≤50 mg/kg total heavy metals as lead
≤500 mg/kg total sulfur as SO4 (ICP)

traços de ânion

chloride (Cl-): ≤50 mg/kg

traços de cátion

As: ≤0.5 mg/kg
Ba: ≤20 mg/kg
Cd: ≤1 mg/kg
Co: ≤1 mg/kg
Cr: ≤10 mg/kg
Cu: ≤5 mg/kg
Hg: ≤0.5 mg/kg
Ni: ≤5 mg/kg
Pb: ≤5 mg/kg
Zn: ≤20 mg/kg

InChI

1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6

chave InChI

QORWJWZARLRLPR-UHFFFAOYSA-H

Procurando produtos similares? Visita Guia de comparação de produtos

Categorias relacionadas

Aplicação


  • Tungstosilicic Acid: A Promising Electrolyte for Redox Flow Battery.: This study explores the use of tungstosilicic acid (TSA) as an electrolyte in redox flow batteries (RFB). The research highlights TSA′s high energy density due to its multi-electron transfer capability, making it a promising candidate for enhancing the efficiency and power density of RFBs. This advancement is particularly relevant for large-scale energy storage systems integrating renewable energy technologies (Sharma et al., 2023).

  • Heterogenization of a Tungstosilicic Acid Catalyst for Esterification of Bio-Oil Model Compound.: This paper explores the heterogenization of tungstosilicic acid by supporting it on silica-based materials for the esterification of bio-oil model compounds. The catalyst shows high activity and stability, indicating its potential for industrial applications in bio-oil upgrading (Prasertpong et al., 2022).


Nota de análise

Phase Composition (by XRD analysis):
ß-TCP: >98% ; Hydroxylapatite: <1.0% ; a-TCP: <0%; TTCP: 0%
other Ca-P phases as Calcium pyrophosphate <1.0%

Código de classe de armazenamento

11 - Combustible Solids

Classe de risco de água (WGK)

WGK 1

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Os clientes também visualizaram

Slide 1 of 3

1 of 3

Hydroxyapatite purum p.a., &#8805;90% (as Ca3(PO4)2, KT)

Sigma-Aldrich

21223

Hydroxyapatite

Calcium phosphate, amorphous nanopowder, &lt;150&#160;nm particle size (BET)

Sigma-Aldrich

693871

Calcium phosphate, amorphous

Fosfato de cálcio suitable for plant cell culture, BioReagent, powder

Sigma-Aldrich

C3161

Fosfato de cálcio

Simon Storgård Jensen et al.
Clinical oral implants research, 17(3), 237-243 (2006-05-05)
The purpose was to qualitatively and quantitatively compare the bone formation and graft resorption of two different bone substitutes used in both orthopedic and oral surgery, with autogenous bone as a positive control. Three standardized bone defects were prepared in
Crystal structure analysis of β-tricalcium phosphate Ca3(PO4)2 by neutron powder diffraction.
Yashima M, et al.
Journal of Solid State Chemistry, 175(2), 272-277 (2003)
S Yamada et al.
Biomaterials, 18(15), 1037-1041 (1997-08-01)
To study the influence of calcium phosphate ceramic solubility on osteoclastic resorption, neonatal rabbit bone cells were cultured for 2 days on hydroxyapatite (HA), beta-tricalcium phosphate (beta-TCP) and two types of biphasic calcium phosphate (BCP) with HA/beta-TCP ratios of 25/75
Michael D Weiden et al.
PloS one, 9(10), e108476-e108476 (2014-10-02)
While exploring the effects of aerosol IFN-γ treatment in HIV-1/tuberculosis co-infected patients, we observed A to G mutations in HIV-1 envelope sequences derived from bronchoalveolar lavage (BAL) of aerosol IFN-γ-treated patients and induction of adenosine deaminase acting on RNA 1
C Lorenzo et al.
Cancer gene therapy, 22(11), 542-551 (2015-10-10)
Interleukin 12 (IL12) is a heterodimeric proinflammatory cytokine that has shown promise as an anticancer agent. However, despite encouraging results in animal models, clinical trials involving IL12 have been unsuccessful due to toxic side effects associated with its systemic administration
Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica